Welcome To The Stem Cell Therapeutics HUB On AGORACOM
Stem Cell is a public biotechnology company focused on the development and commercialization of drug-based therapies to treat central nervous system diseases.
Message: Announces Presentation at EDC's 8th Annual Life Science Conference, BioTech 2009
| April 30, 2009 |
|
Stem Cell Therapeutics Corp. Announces Presentation at EDC's 8th Annual Life Science Conference, BioTech 2009
"Regenerative Medicine - New Frontiers in Cellular and Stem Cell Therapies and Tissue Engineering" |
| CALGARY, ALBERTA--(Marketwire - April 30, 2009) - Stem Cell Therapeutics Corp. (TSX VENTURE:SSS) ("SCT") announces today that Dr. Alan Moore, President and CEO, will be presenting at the EDC's 8th Annual Life Science Conference in Miami, Florida. Dr. Moore was invited to discuss SCT's unique regenerative stem cell therapy and how it will be the frontier of personalized healthcare specifically in the key areas of stroke, traumatic brain injury and multiple sclerosis. The University of Miami will host EDCs 8th Annual Life Science Conference, Biotech 2009, at the Hyatt Regency in downtown Miami. The conference brings regional industry and academia together for one day to preview translational research being done in South Florida, and to explore promising new areas of research and collaboration. About EDC's 8th Annual Life Science Conference, BioTech 2009 (http://www.edc-tech.org/clientupload... ): South Florida is a vast region characterized by unique educational institutions and organizations, both large and small, involved in all aspects of the Life Sciences from research, development and commercialization of novel diagnostic and therapeutic products to world renowned treatment centers that offer the latest advancements in patient care. This year's conference will explore the burgeoning and sometimes controversial field of regenerative medicine, harnessing the body's own power to regenerate. Discussion topics include Stem cell-based treatments for heart disease, diabetes and dental problems; Biomaterials for replacement body parts; the intersection of regenerative medicine and personalized healthcare; and how to handle IP, regulatory, licensing and ethics issues. About Stem Cell Therapeutics Corp.: Stem Cell Therapeutics Corp. is a Canadian public biotechnology company (TSX VENTURE:SSS) focused on the development and commercialization of drug-based therapies to treat central nervous system diseases. SCT is a leader in the development of therapies that utilize drugs to stimulate a patient's own resident stem cells. The Company's programs aim to repair neurological function lost due to disease or injury. SCT's extensive patent portfolio of owned and licensed intellectual property supports the potential expansion into future clinical programs in numerous neurological diseases such as traumatic brain injury, multiple sclerosis, Huntington's disease, Alzheimer's disease, and ALS. |
1 Recommendations
Loading...
Loading...
New Message
Please
login
to post a reply